» Articles » PMID: 34502094

Extracellular Matrix Biomarkers in Colorectal Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Sep 10
PMID 34502094
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The cellular microenvironment composition and changes therein play an extremely important role in cancer development. Changes in the extracellular matrix (ECM), which constitutes a majority of the tumor stroma, significantly contribute to the development of the tumor microenvironment. These alterations within the ECM and formation of the tumor microenvironment ultimately lead to tumor development, invasion, and metastasis. The ECM is composed of various molecules such as collagen, elastin, laminin, fibronectin, and the MMPs that cleave these protein fibers and play a central role in tissue remodeling. When healthy cells undergo an insult like DNA damage and become cancerous, if the ECM does not support these neoplastic cells, further development, invasion, and metastasis fail to occur. Therefore, ECM-related cancer research is indispensable, and ECM components can be useful biomarkers as well as therapeutic targets. Colorectal cancer specifically, is also affected by the ECM and many studies have been conducted to unravel the complex association between the two. Here we summarize the importance of several ECM components in colorectal cancer as well as their potential roles as biomarkers.

Citing Articles

Comprehensive bioinformatic analysis reveals prognostic significance and functional insights of candidate gene expression in colorectal cancer.

Ke T, Chang S, Yeh C, Lin S, Yeh K Sci Rep. 2025; 15(1):5659.

PMID: 39955350 PMC: 11829992. DOI: 10.1038/s41598-025-90025-z.


Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression.

Sabit H, Arneth B, Abdel-Ghany S, Madyan E, Ghaleb A, Selvaraj P Cells. 2024; 13(19).

PMID: 39404428 PMC: 11475877. DOI: 10.3390/cells13191666.


Elevated BEAN1 expression correlates with poor prognosis, immune evasion, and chemotherapy resistance in rectal adenocarcinoma.

Shapaer T, Chen Y, Pan Y, Wu Z, Tang T, Zhao Z Discov Oncol. 2024; 15(1):446.

PMID: 39276259 PMC: 11401830. DOI: 10.1007/s12672-024-01321-5.


Decellularized tissues as platforms for digestive system cancer models.

Seifi Z, Khazaei M, Cheraghali D, Rezakhani L Heliyon. 2024; 10(11):e31589.

PMID: 38845895 PMC: 11153114. DOI: 10.1016/j.heliyon.2024.e31589.


Support Vector Machine-Based Prediction Models for Drug Repurposing and Designing Novel Drugs for Colorectal Cancer.

Sengupta A, Singh S, Kumar R ACS Omega. 2024; 9(16):18584-18592.

PMID: 38680332 PMC: 11044175. DOI: 10.1021/acsomega.4c01195.


References
1.
Kagan H, Li W . Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003; 88(4):660-72. DOI: 10.1002/jcb.10413. View

2.
Hua H, Li M, Luo T, Yin Y, Jiang Y . Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci. 2011; 68(23):3853-68. PMC: 11114831. DOI: 10.1007/s00018-011-0763-x. View

3.
Tahara K, Mimori K, Iinuma H, Iwatsuki M, Yokobori T, Ishii H . Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer. Ann Surg Oncol. 2010; 17(12):3362-9. DOI: 10.1245/s10434-010-1149-2. View

4.
Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I . Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res. 2001; 7(5):1258-62. View

5.
Burke K, Smid M, Dawes R, Timmermans M, Salzman P, van Deurzen C . Using second harmonic generation to predict patient outcome in solid tumors. BMC Cancer. 2015; 15:929. PMC: 4659155. DOI: 10.1186/s12885-015-1911-8. View